ftc report pbms - Search News

Healthcare Leaders Support FTC’s Second Report on PBMs, While PBMs Criticize Findings

On Tuesday, the Federal Trade Commission released its second interim staff report on prescription drug middlemen. The report examines the impact of PBMs (specifically CVS Caremark, Express Scripts and Optum Rx) on specialty generic drugs,

USA Today · 1d

FTC report shows $7.3 billion in drug price inflation by leading pharmacy benefit managers

From 2017 to 2022, the companies marked up prices at their pharmacies by hundreds or thousands of percent, netting them $7.3 billion in revenue.

STAT · 2d

FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

For the second time in less than a year, the FTC has released a highly critical report of pharmacy benefit managers, or PBMs.

CNN on MSN · 1d

FTC finds middlemen inflate specialty generic drug prices by billions of dollars

Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,

The Financial Times · 2d

FTC says pharmacy benefits managers marked-up generic drug prices for $7.3bn gain

Regulator’s report finds companies ‘hiked costs’ for a range of medicines, including cancer and HIV treatments

MedPage Today1d

Major PBMs Inflated Drug Prices, Pocketing $7.3 Billion Along the Way, FTC Says

The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...

Axios Vitals on MSN2d

PBMs made more than $7B marking up specialty generics: FTC

The three biggest pharmacy benefit managers made more than $7.3 billion over five years marking up the prices of specialty ...

Fierce Healthcare2d

FTC: Big 3 PBMs generated $7.3B from specialty generic drug markups

CVS Caremark, Express Scripts and OptumRx dramatically mark up specialty generic drugs to affiliated pharmacies, the Federal ...

1don MSN

PBMs made billions marking up specialty drugs by more than 1,000 percent: FTC

The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying ...

pharmaphorum1d

FTC doubles down on PBM criticism in new report

The new document focuses on the influence of PBMs over the market for specialty generic drugs for illnesses like cancer, ...

Hosted on MSN48m

Report Reveals Billions Made from Generic Drug Price Hikes

A recent Federal Trade Commission report highlights a concerning trend in the pharmaceutical industry, where pharmacy benefit ...

1don MSN

Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says

Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" ...

3hon MSN

UnitedHealth Charged Cancer Patients 5000%, Bombshell FTC Report Claims

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's Express Scripts—marked up prices at their pharmacies by hundreds or thousands ...

FTC Launches Inquiry of Single-Family Rental Home 'Mega Investors,' Issues PBM Report

"While this information is theoretically available to the public, institutional owners' holdings are challenging to identify ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results